ArticleCells2022

Cyclin-Dependent Kinase Subunit 2 (CKS2) as a Prognostic Marker for Stages I-III Invasive Non-Mucinous Lung Adenocarcinoma and Its Role in Affecting Drug Sensitivity.

Junkai Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.